CHP - N-terminal region Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-CHP - N-terminal region antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | CHP - N-terminal region |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | cow, dog, guinea pig, horse, human, mouse, rabbit, rat, zebrafish |
| Isotype | n/a |
| Format | affinity purified |
| Size | 0.1 mL |
| Concentration | n/a |
| Applications | Immunohistochemistry (IHC), Western Blot (WB) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | This is a rabbit polyclonal antibody against CHP. It was validated on Western BlotTarget Description: This gene encodes a phosphoprotein that binds to the Na+/H+ exchanger NHE1. This protein serves as an essential cofactor which supports the physiological activity of NHE family members and may play a role in the mitogenic regulation of NHE1. The protein shares similarity with calcineurin B and calmodulin and it is also known to be an endogenous inhibitor of calcineurin activity. |
| Immunogen | Immunogen: The immunogen is a synthetic peptide directed towards the N terminal region of human CHP |
| Other Names | [calcineurin B homologous protein 1; Calcineurin B homologous protein 1; calcineurin B homologous protein 1; calcineurin like EF-hand protein 1; Calcineurin B-like protein; Calcium-binding protein CHP; Calcium-binding protein p22; EF-hand calcium-binding domain-containing protein p22] |
| Gene, Accession # | [CHP1], Gene ID: 11261, NCBI: NP_009167, UniProt: Q99653 |
| Catalog # | MBS3210722 |
| Price | $365 |
| Order / More Info | CHP - N-terminal region Antibody from MYBIOSOURCE INC. |
| Product Specific References | n/a |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies